Related references
Note: Only part of the references are listed.Quantitative Assessment of Cardiac Hypermetabolism and Perfusion for Diagnosis of Cardiac Sarcoidosis
Robert J. H. Miller et al.
JOURNAL OF NUCLEAR CARDIOLOGY (2022)
Cost-Effectiveness of Tafamidis Therapy for Transthyretin Amyloid Cardiomyopathy
Dhruv S. Kazi et al.
CIRCULATION (2020)
Efficient 1-Hour Technetium-99 m Pyrophosphate Imaging Protocol for the Diagnosis of Transthyretin Cardiac Amyloidosis
Ahmad Masri et al.
CIRCULATION-CARDIOVASCULAR IMAGING (2020)
DPD Quantification in Cardiac Amyloidosis A Novel Imaging Biomarker
Paul R. Scully et al.
JACC-CARDIOVASCULAR IMAGING (2020)
Transthyretin Amyloid Cardiomyopathy JACC State-of-the-Art Review
Frederick L. Ruberg et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2—Diagnostic criteria and appropriate utilization
Sharmila Dorbala et al.
JOURNAL OF NUCLEAR CARDIOLOGY (2019)
Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis: Analysis of the APOLLO Study
Scott D. Solomon et al.
CIRCULATION (2019)
Technetium pyrophosphate uptake in transthyretin cardiac amyloidosis: Associations with echocardiographic disease severity and outcomes
Michael N. Vranian et al.
JOURNAL OF NUCLEAR CARDIOLOGY (2018)
Regional Variation in Technetium Pyrophosphate Uptake in Transthyretin Cardiac Amyloidosis and Impact on Mortality
Brett W. Sperry et al.
JACC-CARDIOVASCULAR IMAGING (2018)
Diagnosis of cardiac amyloidosis: a systematic review on the role of imaging and biomarkers
Panagiota Kyriakou et al.
BMC CARDIOVASCULAR DISORDERS (2018)
National patterns in imaging utilization for diagnosis of cardiac amyloidosis: A focus on Tc99m-pyrophosphate scintigraphy
Serge C. Harb et al.
JOURNAL OF NUCLEAR CARDIOLOGY (2017)
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
Julian D. Gillmore et al.
CIRCULATION (2016)
99mTc-DPD uptake reflects amyloid fibril composition in hereditary transthyretin amyloidosis
Bjorn Pilebro et al.
UPSALA JOURNAL OF MEDICAL SCIENCES (2016)
Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging Predicting Survival for Patients With ATTR Cardiac Amyloidosis
Adam Castano et al.
JAMA CARDIOLOGY (2016)
2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards)
Karen A. Hicks et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Bone scintigraphy with 99mtechnetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis
Andor W. J. M. Glaudemans et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2014)
Quantitative interpretation of FDG PET/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis
Azadeh Ahmadian et al.
JOURNAL OF NUCLEAR CARDIOLOGY (2014)
Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis
David F. Hutt et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2014)
99mTc-Pyrophosphate Scintigraphy for Differentiating Light-Chain Cardiac Amyloidosis From the Transthyretin-Related Familial and Senile Cardiac Amyloidoses
Sabahat Bokhari et al.
CIRCULATION-CARDIOVASCULAR IMAGING (2013)
An administrative data merging solution for dealing with missing data in a clinical registry: adaptation from ICD-9 to ICD-10
Danielle A. Southern et al.
BMC MEDICAL RESEARCH METHODOLOGY (2008)
Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy
E Perugini et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Share Paper
